Increased Nrf2 expression is correlated with decreased survival and increased metastasis in several cancer types, including gastric cancer, glioma, hepatocellular carcinoma, breast cancer, prostate cancer, and small cell and non-small cell lung cancer [16,17,18,19,20]. This evidence concerns the gene NFE2L2 and breast carcinoma.